Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

AMLN Insider Trading

AMLN | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at AMLN provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2005-07-19 03:17 2005-07-18 GREENE HOWARD E JR Director SELL $21.85 3,846 $84,025 1,894,672 -0.2%
2005-07-08 22:00 2005-07-07 BRADBURY DANIEL Officer - Chief Operating Officer SELL $20.50 1,500 $30,750 6,481 -18.8%
2005-07-06 21:42 2005-07-05 GREENE HOWARD E JR Director SELL $21.13 3,846 $81,266 1,898,518 -0.2%
2005-07-06 01:47 2005-07-01 BARON ALAIN D Officer - Sr VP Research OPT+S $20.88 933 $19,481 8,271 0.0%
2005-06-22 19:34 2005-06-20 GREENE HOWARD E JR Director SELL $20.45 3,846 $78,653 1,902,364 -0.2%
2005-06-21 00:37 2005-06-17 GREENE HOWARD E JR Director SELL $20.40 3,846 $78,473 1,906,210 -0.2%
2005-06-17 00:48 2005-06-15 BARON ALAIN D Officer - Sr VP Research OPT+S $19.05 1,866 $35,542 8,271 0.0%
2005-06-17 00:04 2005-06-15 COOK JOSEPH C JR Director, Officer - Chairman of the Board SELL $18.64 24,000 $447,271 1,119,000 -2.1%
2005-05-11 22:52 2005-05-10 EBERHARD CRAIG A Officer - VP Sales BUY $17.35 11,500 $199,525 20,345 +130.0%
2005-05-11 21:24 2005-05-09 ELWOOD DWAYNE M Officer - Sr VP Marketing BUY $16.75 3,500 $58,623 1,477 +100.0%
2005-05-10 20:07 2005-05-06 GREGG TERRANCE H Director BUY $16.37 3,000 $49,110 8,000 +60.0%
2005-05-10 01:38 2005-05-06 BRYSON VAUGHN D Director BUY $16.72 20,000 $334,300 126,013 +18.9%
2005-05-07 00:23 2005-05-06 GRAHAM GINGER L Officer - President and Chief Executive BUY $16.65 12,000 $199,800 118,535 +11.3%
2005-04-26 02:21 2005-04-25 BARON ALAIN D Officer - Sr VP Research OPT+S $19.00 933 $17,727 6,521 0.0%
2005-03-16 04:05 2005-03-15 GREENE HOWARD E JR Director SELL $20.00 3,846 $76,920 1,911,056 -0.2%
2005-03-02 21:51 2005-03-01 KOLTERMAN ORVILLE G Officer - Sr VP Clinical Affairs OPT+S $21.31 2,200 $46,882 94,833 0.0%
2005-03-02 21:51 2005-03-01 BARON ALAIN D Officer - Sr VP Research OPT+S $21.31 933 $19,882 6,521 0.0%
2005-03-01 01:26 2005-02-28 GREENE HOWARD E JR Director SELL $21.40 3,846 $82,291 1,914,902 -0.2%
2005-02-15 03:02 2005-02-14 GREENE HOWARD E JR Director SELL $22.47 3,846 $86,403 1,918,748 -0.2%
2005-02-08 03:19 2005-02-07 BRADBURY DANIEL Officer - Chief Operating Officer SELL $23.00 1,500 $34,500 8,081 -15.7%
2005-02-03 01:55 2005-02-01 KOLTERMAN ORVILLE G Officer - Sr VP Clinical Affairs OPT+S $22.08 3,000 $66,240 94,833 0.0%
2005-02-03 01:55 2005-02-01 BARON ALAIN D Officer - Sr VP Research OPT+S $22.08 933 $20,601 6,521 0.0%
2005-02-02 02:13 2005-01-31 GREENE HOWARD E JR Director SELL $22.15 3,846 $85,207 1,922,594 -0.2%
2005-01-19 21:54 2005-01-18 GREENE HOWARD E JR Director SELL $23.27 3,846 $89,496 1,926,440 -0.2%
2005-01-07 19:38 2005-01-05 BRADBURY DANIEL Officer - Chief Operating Officer SELL $22.66 1,000 $22,660 9,581 -9.5%
2005-01-04 02:25 2005-01-03 GREENE HOWARD E JR Director SELL $23.46 3,846 $90,241 1,930,286 -0.2%
2005-01-03 21:12 2004-12-30 ROWLAND LLOYD A Officer - VP Legal & General Counsel OPT+S $23.47 2,500 $58,675 8,730 0.0%
2005-01-04 02:25 2005-01-03 KOLTERMAN ORVILLE G Officer - Sr VP Clinical Affairs OPT+S $23.63 3,000 $70,890 94,410 0.0%
2005-01-04 02:25 2005-01-03 BARON ALAIN D Officer - Sr VP Research OPT+S $23.39 934 $21,848 5,954 0.0%
2005-01-03 21:13 2004-12-31 FOLETTA MARK G Officer - VP Finance & CFO OPT+S $23.50 3,000 $70,500 19,262 0.0%
2004-12-21 03:08 2004-12-20 GREENE HOWARD E JR Director SELL $22.73 3,846 $87,425 1,934,132 -0.2%
2004-12-16 20:24 2004-12-15 ROWLAND LLOYD A Officer - VP Legal & General Counsel OPT+S $22.60 2,500 $56,494 8,730 0.0%
2004-12-16 01:56 2004-12-14 BROWN MARTIN R Officer - Sr VP Human Resources and Corp SELL $22.16 4,000 $88,656 139,274 -2.8%
2004-12-08 02:31 2004-12-07 BRADBURY DANIEL Officer - Chief Operating Officer SELL $21.48 1,000 $21,475 12,581 -7.4%
2004-12-07 03:56 2004-12-06 GREENE HOWARD E JR Director SELL $21.11 3,846 $81,196 1,937,978 -0.2%
2004-12-02 01:27 2004-12-01 KOLTERMAN ORVILLE G Officer - Sr VP Clinical Affairs OPT+S $20.07 3,000 $60,210 94,410 0.0%
2004-12-02 01:27 2004-12-01 BARON ALAIN D Officer - Sr VP Research OPT+S $20.07 934 $18,746 5,954 0.0%
2004-12-01 01:28 2004-11-30 FOLETTA MARK G Officer - VP Finance & CFO OPT+S $20.35 3,000 $61,050 19,262 0.0%
2004-11-23 02:16 2004-11-22 GREENE HOWARD E JR Director SELL $21.19 3,846 $81,486 1,941,824 -0.2%
2004-11-13 00:30 2004-11-12 BROWN MARTIN R Officer - Sr VP Human Resources and Corp SELL $22.86 4,000 $91,450 143,274 -2.7%
2004-11-10 19:39 2004-11-08 GREENE HOWARD E JR Director SELL $23.17 3,846 $89,124 1,945,670 -0.2%
2004-11-08 19:56 2004-11-05 BRADBURY DANIEL Officer - Chief Operating Officer SELL $23.15 1,000 $23,150 13,581 -6.9%
2004-11-02 00:12 2004-11-01 BARON ALAIN D Officer - Sr VP Research OPT+S $21.01 934 $19,623 5,954 0.0%
2004-11-02 00:12 2004-10-29 FOLETTA MARK G Officer - VP Finance & CFO OPT+S $21.05 3,000 $63,143 19,262 0.0%
2004-10-27 01:09 2004-10-26 GREENE HOWARD E JR Director SELL $20.00 3,846 $76,920 1,949,516 -0.2%
2004-10-15 02:27 2004-10-14 BROWN MARTIN R Officer - Senior Vice President SELL $19.11 4,000 $76,429 137,274 -2.8%
2004-10-12 18:45 2004-10-11 GREENE HOWARD E JR Director SELL $20.31 3,846 $78,100 1,953,362 -0.2%
2004-10-08 00:12 2004-10-07 BRADBURY DANIEL Officer - Chief Operating Officer SELL $20.75 1,000 $20,750 14,691 -6.4%
2004-10-05 01:43 2004-10-01 BARON ALAIN D Officer - Senior VP Clinical Research OPT+S $21.57 934 $20,146 5,954 0.0%
2004-09-29 01:46 2004-09-28 GREENE HOWARD E JR Director SELL $20.00 3,846 $76,923 1,957,208 -0.2%
SHOW ENTRIES

How to Interpret $AMLN Trades

Not every insider transaction in AMLN is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $AMLN shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for AMLN

Insider activity data for AMLN is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $AMLN, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.